Immunotherapy in fungal allergy.

@article{Helbling2003ImmunotherapyIF,
  title={Immunotherapy in fungal allergy.},
  author={Arthur Helbling and Andrea Reimers},
  journal={Current allergy and asthma reports},
  year={2003},
  volume={3 5},
  pages={447-53}
}
For decades airborne fungal spores have been implicated as causative factors in respiratory allergy. Exposure to high atmospheric spore counts and sensitization to specific fungal allergens have been associated with severe asthma, mainly in young adults. Although the prevalence of sensitization to commercial fungal extracts is approximately 3% in epidemiologic studies, in selected patients, particularly with asthma, the sensitization rate might increase to 30%. Of the estimated number of more… CONTINUE READING